Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection

Omadacycline, a first-in-class aminomethylcycline antibiotic, is approved in the USA as intravenous (IV) and/or oral therapy for treatment of adults with community-acquired bacterial pneumonia (CABP) or acute bacterial skin and skin structure infections (ABSSSI). Phase 1 and 3 studies indicate that...

Descripción completa

Detalles Bibliográficos
Autores principales: Leviton, Ira M., Amodio-Groton, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861994/
https://www.ncbi.nlm.nih.gov/pubmed/35192150
http://dx.doi.org/10.1007/s40261-022-01119-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861994/
https://www.ncbi.nlm.nih.gov/pubmed/35192150
http://dx.doi.org/10.1007/s40261-022-01119-9

Ejemplares similares